title: H2 receptor antagonist usage in Missouri Medicaid recipients.
authors.forename: K C
authors.initials: KC
authors.lastname: Douglas
authors.forename: A M
authors.initials: AM
authors.lastname: Dykstra
authors.forename: W
authors.initials: W
authors.lastname: Fitzpatrick
authors.forename: L
authors.initials: L
authors.lastname: Lowrey
authors.forename: T R
authors.initials: TR
authors.lastname: Prosser
authors.forename: D R
authors.initials: DR
authors.lastname: Rush
authors.forename: W J
authors.initials: WJ
authors.lastname: Stelmach
mesh_terms: D004363:Drug Utilization / Q000191:economics; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000706:statistics & numerical data*; D008484:Medicaid / Q000706:statistics & numerical data*; D008923:Missouri; D010437:Peptic Ulcer / Q000188:drug therapy*; D014481:United States
chemical_list: D006635:Histamine H2 Antagonists